Enzyme-nanoparticle conjugates for biomedical applications.

Methods Mol Biol

Department of Bioengineering, Clemson University, Clemson, SC, USA.

Published: January 2011

Enzymes hold a great promise as therapeutic agents because of their unique specificity and high level of activity. Yet, clinically important enzyme drugs are for less common than conventional low molecular weight drugs due to a number of disadvantages. Most important among these are poor stability, potential immunogenicity, and potential systemic toxicity. Recent developments in synthesis and characterization of nanoparticles and exciting novel properties of some classes of nanomaterials have boosted interest in the potential use of nanoparticles as carriers of enzyme drugs. In certain cases, use of enzymes attached to nanoparticles can help to overcome some of the above problems and improve the prospects of clinical applications of enzyme drugs. Here, we review recent data on the use of nanoparticles as carriers for several clinically important enzyme drugs and discuss advantages and potential limitations of such constructs. While promising preliminary results were obtained with regard to their performance in vitro and in some animal models, further investigations and clinical trials, as well as addressing regulatory issues, are warranted to make these delivery systems suitable for clinical applications.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-60761-895-9_14DOI Listing

Publication Analysis

Top Keywords

enzyme drugs
16
clinically enzyme
8
nanoparticles carriers
8
clinical applications
8
drugs
5
enzyme-nanoparticle conjugates
4
conjugates biomedical
4
biomedical applications
4
applications enzymes
4
enzymes hold
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!